CO-DRX.COM

Co-D Therapeutics

Mission & Vision. News & Events. Co-D in the News. Polymeric micelle technology may enhance drug delivery to solid tumors. Triolimus is a 3-in-1 nanomedicine that carries paclitaxel, rapamycin, and 17-AAG for combination cancer therapy. Co-D is seeking to establish strategic partnerships to develop the company’s nano-medicine programs. An innovative drug development company dedicated to bringing to market first-in-class,. Combination nanomedicines with high safety profiles to treat cancer.

http://www.co-drx.com/

OVERVIEW OF co-drx.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

15

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR CO-DRX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.3 out of 5 with 11 reviews

5 star

1

4 star

5

3 star

3

2 star

0

1 star

2

Hey there! Start your review of co-drx.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

6.4 seconds

CONTACTS AT CO-DRX.COM

Abdalla Saad

1625 K●●●●●●ll Way

Uni●●●205

Ma●●on , Wisconsin, 53718

United States

608●●●655

aa●●●●@wisc.edu

View this contact

Abdalla Saad

1625 K●●●●●●ll Way

Uni●●●205

Ma●●on , Wisconsin, 53718

United States

608●●●655

aa●●●●@wisc.edu

View this contact

Abdalla Saad

1625 K●●●●●●ll Way

Uni●●●205

Ma●●on , Wisconsin, 53718

United States

608●●●655

aa●●●●@wisc.edu

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2013 September 06
UPDATED: 2013 September 06
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

12

YEARS
1

MONTHS
29

DAYS

NAME SERVERS

1: ns77.domaincontrol.com
2: ns78.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

PAGES IN
THIS WEBSITE

15

SSL

EXTERNAL LINKS

1

SITE IP

162.210.50.126

LOAD TIME

6.391 sec

SCORE

6.2

PAGE TITLE

Co-D Therapeutics | co-drx.com Reviews

<META> DESCRIPTION

Mission & Vision. News & Events. Co-D in the News. Polymeric micelle technology may enhance drug delivery to solid tumors. Triolimus is a 3-in-1 nanomedicine that carries paclitaxel, rapamycin, and 17-AAG for combination cancer therapy. Co-D is seeking to establish strategic partnerships to develop the company’s nano-medicine programs. An innovative drug development company dedicated to bringing to market first-in-class,. Combination nanomedicines with high safety profiles to treat cancer.

<META> KEYWORDS

1 co d therapeutics

2 navigation

3 about co d

4 management

5 board of directors

6 advisory board

7 career opportunities

8 technology

9 combination therapy

10 pipeline

CONTENT

Page content here

KEYWORDS ON PAGE

co d therapeutics,navigation,about co d,management,board of directors,advisory board,career opportunities,technology,combination therapy,pipeline,triolimus,partnering,press releases,events,publications,presentations,about us,news and events,careers

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Co-D Therapeutics | co-drx.com Reviews

https://co-drx.com

Mission & Vision. News & Events. Co-D in the News. Polymeric micelle technology may enhance drug delivery to solid tumors. Triolimus is a 3-in-1 nanomedicine that carries paclitaxel, rapamycin, and 17-AAG for combination cancer therapy. Co-D is seeking to establish strategic partnerships to develop the company’s nano-medicine programs. An innovative drug development company dedicated to bringing to market first-in-class,. Combination nanomedicines with high safety profiles to treat cancer.

INTERNAL PAGES

co-drx.com

1

Advisory Board | Co-D Therapeutics

http://co-drx.com/about-co-d/advisory-board

Mission & Vision. Polymeric Micelle – Combination Drug Delivery. News & Events. Co-D in the News. Kevin Kozak, M.D., Ph.D. Co-Founder and Chief Medical Officer. Glen Kwon, Ph.D. Co-Founder and Chief Scientific Officer. News & Events. Co-D Therapeutics Granted Orphan Designation for Triolimus for the Treatment of Angiosarcoma. FDA grants orphan drug status to Madison company’s drug treatment. Expression of angiopoietin-TIE system components in angiosarcoma.

2

Publications | Co-D Therapeutics

http://co-drx.com/category/publications

Mission & Vision. Polymeric Micelle – Combination Drug Delivery. News & Events. Co-D in the News. RSS feed for this section. August 26, 2013. Expression of angiopoietin-TIE system components in angiosarcoma. Http:/ www.ncbi.nlm.nih.gov/pubmed/23558570. Continue Reading →. February 20, 2013. Angiosarcoma Outcomes and Prognostic Factors: A 25-Year Single Institution Experience. Http:/ www.ncbi.nlm.nih.gov/pubmed/23428947. Continue Reading →. October 10, 2012. Continue Reading →. August 14, 2012. FDA grants...

3

Triolimus | Co-D Therapeutics

http://co-drx.com/pipeline

Mission & Vision. Polymeric Micelle – Combination Drug Delivery. News & Events. Co-D in the News. News & Events. Co-D Therapeutics Granted Orphan Designation for Triolimus for the Treatment of Angiosarcoma. FDA grants orphan drug status to Madison company’s drug treatment. Expression of angiopoietin-TIE system components in angiosarcoma. Angiosarcoma Outcomes and Prognostic Factors: A 25-Year Single Institution Experience. Three-in-one Nanomedicine Packs Powerful Punch in Early Cancer Studies.

4

About Co-D | Co-D Therapeutics

http://co-drx.com/about-co-d

Mission & Vision. Polymeric Micelle – Combination Drug Delivery. News & Events. Co-D in the News. Co-D Therapeutics, Inc. is a preclinical stage biopharmaceutical company based in Madison, Wisconsin. Co-D is an innovative drug development company dedicated to developing first-in-class combination nano-medicines with high safety profiles to treat cancer. Co-D’s nanotechnology based polymeric micelle delivery system enables the formulation and combinatorial delivery of multiple anticancer agent...

5

News & Events | Co-D Therapeutics

http://co-drx.com/news-events

Mission & Vision. Polymeric Micelle – Combination Drug Delivery. News & Events. Co-D in the News. News & Events. News & Events. Co-D in the News. Publications & Presentations. News & Events. Co-D Therapeutics Granted Orphan Designation for Triolimus for the Treatment of Angiosarcoma. FDA grants orphan drug status to Madison company’s drug treatment. Expression of angiopoietin-TIE system components in angiosarcoma. Angiosarcoma Outcomes and Prognostic Factors: A 25-Year Single Institution Experience.

UPGRADE TO PREMIUM TO VIEW 10 MORE

TOTAL PAGES IN THIS WEBSITE

15

OTHER SITES

co-driversphoto.com

Co-driver´s Photo

co-driving.com

co-driving - Domain-Registration

Sie sind der Besitzer dieser Adresse und möchten folgendes tun:. Co-driving.com weiterleiten auf eine andere Domain. Co-driving.com einem bestehenden Hostingaccount hinzufügen. Falls Sie nicht der inhaber der Domain co-driving.com sind, so haben Sie vermutlich nach Informationen zum Thema "co-driving.com" gesucht und sind dann hier gelandet. Hier. Können Sie direkt bei Google nach co-driving. Geben Sie Ihre Suchbegriffe ein. Sie sind Inhaber der Domain co-driving.com und haben eine Frage? Thema: Nameserv...

co-driving.ru

Driving - Главная

8592; предыдущая программа. Следующая программа →. Управляющий партнёр. Руководитель проекта. Коуч. Бизнес-тренер. Drive-Спикер.

co-drs.com

CO-DRS

In Physics/Maths and an MBA from Harvard and MIT. He is a founder of Alphameric plc, and of Neural Technologies Ltd. He has eight years experience as a quoted plc director and has been consulting for 17 years. Ken is a graduate Chartered Accountant with 20 years experience of the IT Industry and the City. He worked for Deloittes in. Before becoming FD of Alphameric plc. He has been consulting for 11 years, and acts as FD for a number of companies. Ian Craig-Wood MA MBA. The Chalet, Peaslake,. Or Hampshir...

co-druck.ch

C&O AG Druckerei Rheintal Digitaldruck Offsetdruck

Tel 071 722 43 33. Fax 071 722 78 42. Die kleine Druckerei, die Grosses leistet! Bull; Qualität. Bull; Kundennähe. Bull; Flexibilität. Bull; Zuverlässigkeit. Das sind einige unserer Markenzeichen. Mit Herzblut, Know-how, modernster Technologie und motivierten Mitarbeitern setzen wir uns täglich für die Wünsche unserer Kunden ein. Couvert- und Offsetdruck AG.

co-drx.com

Co-D Therapeutics

Mission & Vision. News & Events. Co-D in the News. Polymeric micelle technology may enhance drug delivery to solid tumors. Triolimus is a 3-in-1 nanomedicine that carries paclitaxel, rapamycin, and 17-AAG for combination cancer therapy. Co-D is seeking to establish strategic partnerships to develop the company’s nano-medicine programs. An innovative drug development company dedicated to bringing to market first-in-class,. Combination nanomedicines with high safety profiles to treat cancer.

co-dsn.com

co-design

Сайт находится на реконструкции.

co-dtp-schulungen.de

Cosmas Oberliesen DTP-Schulungen

Auf der Internetseite von. Auf den folgenden Seiten möchte ich. Mich und mein Angebot an Schulungen. Im professionellen Print-Bereich am. Alle Schulungen die ich anbiete. Sind als Einzelunterricht konzipiert. Weiterhin biete ich auf Anfrage auch. In-House Schulungen für mehrere. Alle Schulungen 25 €/Std. Ermäßigter Satz für Studenten 20 €/Std. Buchen Sie 10 Std. und zahlen nur für 9.

co-du-18.skyrock.com

co-du-18's blog - tecktonic,om,tennis,humour - Skyrock.com

Tecktonic,om,tennis, humour. 09/02/2008 at 3:14 AM. 11/10/2008 at 6:02 AM. Subscribe to my blog! Don't forget that insults, racism, etc. are forbidden by Skyrock's 'General Terms of Use' and that you can be identified by your IP address (66.160.134.14) if someone makes a complaint. Please enter the sequence of characters in the field below. Posted on Saturday, 11 October 2008 at 6:03 AM. Please enter the sequence of characters in the field below. Posted on Monday, 18 August 2008 at 4:47 AM. Please enter ...

co-du-25.skyrock.com

Blog de co-du-25 - MlL' C0o'C0o . . . 0n Skaii' - Skyrock.com

Mot de passe :. J'ai oublié mon mot de passe. MlL' C0o'C0o . . . 0n Skaii'. Brav0 Tpx Rm0.nT Mnt =P. Mise à jour :. Saa S'pass pαrr làà mtnn' . . . ='D Saa S'. Abonne-toi à mon blog! Saa S'pass pαrr làà mtnn' . . . ='D. Saa S'pass pαrr làà mtnn' . . . ='D. Saa S'pass pαrr làà mtnn' . . . ='D. Saa S'pass pαrr làà mtnn' . . . ='D. Ou poster avec :. Retape dans le champ ci-dessous la suite de chiffres et de lettres qui apparaissent dans le cadre ci-contre. Posté le mercredi 02 juillet 2008 04:35.

co-du-29.skyrock.com

Blog de co-du-29 - [x] o°O°o Coé o°O°o [x] - Skyrock.com

Mot de passe :. J'ai oublié mon mot de passe. X] o O o Coé o O o [x]. NeW Blog Psk Ma Tite Vie A Bcp ChanGé! RaGeuX - CrOix RouGe En HaUt A DrOite! Pour Les Autre BienVenU Et Laché Vos Coms! Mise à jour :. Abonne-toi à mon blog! N'oublie pas que les propos injurieux, racistes, etc. sont interdits par les conditions générales d'utilisation de Skyrock et que tu peux être identifié par ton adresse internet (67.219.144.114) si quelqu'un porte plainte. Ou poster avec :. Posté le lundi 20 février 2006 15:12.